Authors
Carolina Makowski, Alexey Shadrin, Sara E Stinson, Nora R Bakken, Helga Ask, Alexandra Havdahl, Anders M Dale, Ole A Andreassen, Dennis van der Meer
Published in
Biological psychiatry. Nov 17, 2026. Epub Nov 17, 2026.
Abstract
Anorexia Nervosa (AN) has the highest mortality rate of any psychiatric disorder yet lacks effective treatments. While recent genomic efforts have reframed AN as a metabo-psychiatric condition that overlaps with cardiometabolic traits, AN's relationship to circulating metabolomic markers remains unknown.
We examined shared genetic architecture between AN and 249 metabolomic biomarkers, and compared profiles with related mental health, anthropometric and cardiometabolic traits. Genetic and biological overlap was assessed with global genetic correlations, conjunctional false discovery rate, bivariate Gaussian mixture modeling, and gene set enrichment analysis across body tissues. We also explored putative causal relationships between AN, body mass index (BMI), and metabolomic biomarkers.
Significant genetic correlations emerged between AN and 142 metabolomic biomarkers, which were opposite in direction to cardiometabolic traits such as BMI and type 2 diabetes (rs<-0.94), and stronger than correlations with anxiety. Shared variants between AN and metabolomic biomarkers, particularly lipid-based metabolites, exhibited a mixture of positive and negative effects. These were mapped to genes involved in lipid-related cell signals, developmental growth, and inflammation, and were widely expressed in the brain, most internal organs and female reproductive organs. Bidirectional associations between AN and metabolomic biomarkers were found to act through their respective influence on BMI.
These findings reveal a complex, bidirectional mixture of positive and negative genetic relationships between AN and systemic metabolism, which would be obscured by examination of broader cardiometabolic traits. Uncovering specific shared lipid and developmental pathways provides a genetically-anchored mechanistic understanding of the illness, while highlighting promising metabolomic targets for weight restoration approaches.
PMID:
43044718
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0